CVS Health Corporation (LON:0HRS)
| Market Cap | 76.16B |
| Revenue (ttm) | 291.39B |
| Net Income (ttm) | 348.91M |
| Shares Out | n/a |
| EPS (ttm) | 0.28 |
| PE Ratio | 218.28 |
| Forward PE | 11.33 |
| Dividend | 2.03 (2.57%) |
| Ex-Dividend Date | Oct 23, 2025 |
| Volume | 7,647 |
| Average Volume | 5,022 |
| Open | 78.38 |
| Previous Close | 78.98 |
| Day's Range | 78.29 - 79.40 |
| 52-Week Range | 43.56 - 85.80 |
| Beta | 0.48 |
| RSI | 49.72 |
| Earnings Date | Oct 29, 2025 |
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial numbers in USD Financial StatementsNews
Can CVS Health Maintain Its Growth Through the End of 2025?
The company's prospects are looking up.
Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Systems on CVS Caremark Commercial Template Formularies
FT. LAUDERDALE, Fla.--(BUSINESS WIRE)-- #TRUEMETRIX--Trividia Health, Inc., announced today that it's TRUE METRIX® Self-Monitoring Blood Glucose Systems are now preferred for commercial patients on CV...
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
CVS Sees Target Price Raised by TD Cowen Analyst Amidst Continual "Buy" Rating | CVS ...
CVS Sees Target Price Raised by TD Cowen Analyst Amidst Continual "Buy" Rating | CVS Stock News
Validea Detailed Fundamental Analysis - CVS
Below is Validea's guru fundamental report for CVS HEALTH CORP (CVS). Of the 22 guru strategies we follow, CVS rates highest using our Multi-Factor Investor model based on the published strategy of Pi...
CVS Health: Undervalued And Ripe For Growth
CVS Health management raised 2025 EPS guidance, projecting robust double-digit earnings growth. Click here to read why CVS stock is a Buy.
CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity
WOONSOCKET, R.I. , Oct. 31, 2025 /PRNewswire/ -- CVS Pharmacy® customers donated more than $3 million this year to support local food banks across the country, and CVS Health® (NYSE: CVS) is boosting ...
What the Options Market Tells Us About CVS Health
High-rolling investors have positioned themselves bearish on CVS Health (NYSE: CVS), and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's ...
CVS Stock: Evercore ISI Raises Price Target to $95, Maintains Outperform Rating | CVS Stock News
CVS Stock: Evercore ISI Raises Price Target to $95, Maintains Outperform Rating | CVS Stock News
CVS Health Corp (CVS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised EPS ...
CVS Health Corp (CVS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised EPS Guidance
Guru Fundamental Report for CVS
Below is Validea's guru fundamental report for CVS HEALTH CORP (CVS). Of the 22 guru strategies we follow, CVS rates highest using our Multi-Factor Investor model based on the published strategy of Pi...
My Top 10 High-Yield Picks For November 2025: One Yields 9%+
I present a diversified selection of high-yield dividend stocks with strong income and growth potential, including CVX, VZ, MO, ARCC, and others. Each company was selected for sustainable dividends, a...
CVS Stock Slips as $5.7 Billion Charge Overshadows Record Results
CVS Stock Slips as $5.7 Billion Charge Overshadows Record Results
Q3 2025 CVS Health Corp Earnings Call Transcript
Q3 2025 CVS Health Corp Earnings Call Transcript
CVS Health (CVS): Cantor Fitzgerald Raises Price Target to $95 | CVS Stock News
CVS Health (CVS): Cantor Fitzgerald Raises Price Target to $95 | CVS Stock News
CVS Health (CVS) Analyst Rating Update: Target Price Raised by Truist Securities | CVS Stock News
CVS Health (CVS) Analyst Rating Update: Target Price Raised by Truist Securities | CVS Stock News
Decoding CVS Health Corp (CVS): A Strategic SWOT Insight
Decoding CVS Health Corp (CVS): A Strategic SWOT Insight
Why CVS Buying Oak Street Health in 2023 Was One of Worst Healthcare Deals in Recent Years
CVS Health Reports Strong Q3 Results and Raises EPS Guidance
CVS Health Reports Strong Q3 Results and Raises EPS Guidance
FDA Pushback Prompts Akebia To Drop Broad Label Pursuit For Kidney Disease Drug
Akebia Therapeutics Inc. (NASDAQ: AKBA) stock is trading lower on Wednesday. The kidney disease company met with the U.S. Food and Drug Administration (FDA) and has not reached an agreement on a path...
CVS Health (CVS) Raises Full-Year 2025 Earnings Guidance
CVS Health (CVS) Raises Full-Year 2025 Earnings Guidance
Heard on the Street: UnitedHealth and CVS are pruning their Medicare Advantage businesses to favor profit over size
UnitedHealth and CVS are pruning their Medicare Advantage businesses to favor profit over size
CVS Health (CVS) Stock Rises on Strong Q3 Earnings and Raised Guidance
CVS Health (CVS) Stock Rises on Strong Q3 Earnings and Raised Guidance
CVS Prioritizes Membership Growth Over Expanding Clinic Numbers
CVS Prioritizes Membership Growth Over Expanding Clinic Numbers